Search Results
Mar 12, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines - RARE
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-ultragenyx-pharmaceutical-inc-of-class-action-lawsuit-and-upcoming-deadlines--rare-302712003.htmlSOURCE
More news about: Pomerantz LLP
Mar 12, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
for purported optimal effect. Inovio's lead product candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis ("RRP"), a life-long, rare disease of the respiratory tract caused by HPV infection. At all relevant times, Defendants touted the prospects of the U.S. Food and Drug Administration
More news about: Pomerantz LLP
Mar 12, 2026, 09:45 ET Medical Knowledge Group Appoints David Margines to Board of Directors, Advancing Its Legacy in AI- and Analytics-Driven Drug Commercialization
teams, and delivering enterprise software and solutions. His combination of product leadership, operational scaling, and go-to-market strategy brings a rare, full-spectrum perspective to MKG's scalable and non-linear growth strategy.David graduated from Yale University with a degree in Ethics, Politics,
More news about: Medical Knowledge Group
Mar 12, 2026, 09:05 ET Kura Sushi USA and JUJUTSU KAISEN Reunite to Ignite Thrills with Bikkura Pon Dining Experience
order.kurasushi.com, and DoorDash, except for the rare Yuji Itadori Acrylic Carabiner.*Conjure the flavor:Spicy Tantanmen: Inspired by Yuji Itadori's Black Flash—ramen
More news about: Kura Sushi USA, Inc.
Mar 12, 2026, 09:05 ET BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
Patient Information.About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael,
More news about: BioMarin Pharmaceutical Inc.
Mar 12, 2026, 09:00 ET National Organization for Rare Disorders and OpenEvidence Partner to Bring AI-Powered Rare Disease Resources to Clinicians and Patients Worldwide
Organization for Rare Disorders (NORD®) and OpenEvidence today announced a new partnership to expand access to trusted, expert-reviewed rare disease information for clinicians, patients and families.Together, NORD and OpenEvidence will help build and scale a growing library of rare disease summaries
More news about: National Organization for Rare Disorders (NORD®)
Mar 12, 2026, 09:00 ET Wine Market Journal Reports Bull Market for Rare Wine Accelerating
standard for rare wine values, The Wine Market Journal, today announced that the rare wine market
More news about: Benchmark Wine Group
Mar 12, 2026, 09:00 ET Century Health and Dallas Renal Group Partner to Unlock Real-World Insights on Rare Kidney Diseases
Rare kidney diseases such as IgA nephropathy and C3 glomerulopathy are difficult to track in electronic records because key diagnostic signals often live in reports and notes Century Health's AI will identify and structure signals across practices, creating
More news about: Century Health
Mar 12, 2026, 09:00 ET The Ritz-Carlton Yacht Collection Unveils a New Winter 2027-2028 Season of Voyages Aboard Evrima, Ilma, and Luminara
Puerto Chiapas, each revealing distinct cultural character and coastal beauty. In addition, two seven-night voyages from San Juan to Panama City offer a rare opportunity to pass through the Panama Canal, where guests can witness its architectural marvels from the private terraces of Evrima's all-suite
More news about: Marriott International, Inc.
Mar 12, 2026, 08:45 ET Express Celebrates Top Performers and Purpose‑Driven Leadership at International Leadership Conference in Nashville
helped shape countless careers while fostering environments where employees and franchise owners feel supported and empowered. His steady leadership and rare combination of humility and intensity left a lasting impression on Bob Funk Sr., who personally supported the creation of this award in Gill's honor.Bill
More news about: Express Services dba Express Employment Professionals
Mar 12, 2026, 08:41 ET Dr. Ronn Hale II Announces National Book Tour for "The Power of a Kingdom Mindset," A Blueprint for Leadership, Identity, and Generational Impact
Cleveland, Chicago, Pittsburg, Atlanta, Detroit, and the Washington, D.C. area. Known as "The Kingdom Mindset Strategist," Dr. Hale brings a rare combination of church leadership and marketplace credibility to the national conversation around identity, mental resilience, and generational leadership.
More news about: Dr. Ronn Hale
Mar 12, 2026, 08:01 ET American College of Medical Genetics and Genomics (ACMG) Clinical Genetics Meeting: Genomics presents new research highlighting underdiagnosis of rare genetic disorders
New research advances genetic diagnosisDemonstrates the potential to expand equitable access to treatment for patients living with rare inherited metabolic and neurodegenerative diseasesBALTIMORE, March 12,
More news about: Genomics Limited
Mar 12, 2026, 08:00 ET MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
https://globalrarediseasecommission.com/pressrelease-2024eoyreport/Rare Diseases: Individually Rare, Collectively Common. The Lancet Diabetes & Endocrinology, vol. 11, no. 3, 2023.Pandey, R., et al. "A meta-analysis of diagnostic yield and clinical utility of genome and exome sequencing in pediatric rare and undiagnosed genetic
More news about: MyOme, Inc
Mar 12, 2026, 08:00 ET Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
Officer. Dr. Hayward brings more than 26 years of global experience in the healthcare industry, including leadership in oncology, haemato-oncology, and rare diseases, with the last six years focused on radiopharmaceuticals and translational medicine.
More news about: Ratio Therapeutics Inc.
Mar 12, 2026, 08:00 ET Atossa Therapeutics Presents Clinical Trial Update Highlighting (Z)-Endoxifen Research at the 2026 MDA Clinical & Scientific Conference
Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other rare disease indications with significant unmet need, presented an oral clinical trial update on (Z)-endoxifen at the MDA Clinical & Scientific Conference
More news about: Atossa Therapeutics Inc
Mar 12, 2026, 08:00 ET Locksley Achieves 99.5% Purity Antimony Trioxide, Advancing U.S. Supply Chain Capability
Limited is focused on critical minerals in the United States of America. The Company is actively advancing the Mojave Project in California, targeting rare earth elements (REEs) and antimony. Locksley is executing a mine-to-market strategy for antimony, aimed at re-establishing domestic supply chains for
More news about: Locksley Resources
Mar 12, 2026, 07:58 ET Pierre Fabre Pharmaceuticals Announces Type A Meeting Agreed with U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA)
Pharmaceuticals and Pierre Fabre LaboratoriesThe mission of Pierre Fabre Pharmaceuticals (PFP) is to deliver breakthrough therapies in oncology and rare diseases to patient populations with high unmet needs and limited treatment options. Our belief is that every time we care for a single person, we make
More news about: Pierre Fabre Pharmaceuticals
Mar 12, 2026, 07:30 ET Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
immunotherapy.Cohort B: There has been a total of twenty-five (25) SOC-related grade 3 AEs, of which four (4) are considered common or rare side effects of immune checkpoint inhibitors (three grade 3 and one grade 4).The safety data for patients who received INT230-6 plus SOC
More news about: Intensity Therapeutics Inc.
Mar 12, 2026, 07:09 ET Newport LLC Welcomes AI and Cybersecurity Strategist George Tsantes as Partner to Help Mid-Market and Enterprise Leaders Navigate the Intelligent Era
35 years at the intersection of financial services, AI, and cybersecurity and boardroom advisory experience trusted by global firms, Tsantes brings rare, deployable expertise to Newport's growing mid-Atlantic advisory team.
More news about: Newport LLC
Mar 12, 2026, 06:00 ET More Perfect Partners with Generation Citizen to Incorporate Digital Media Literacy into Experiential Civic Education and Expand High School Voter Registration Efforts
Project, and RISE Vote 2026, a nonpartisan high school voter registration and pre-registration initiative."Generation Citizen has built something rare: a civic education model that does not just teach young people about democracy, but empowers them to engage with it," said John Bridgeland, Founder
More news about: More Perfect
Mar 12, 2026, 04:58 ET ImmunoForge to Conduct Strategic Partnering at Bio-Europe Spring 2026
March 12, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a biopharmaceutical company developing treatments for rare diseases, announced that they will participate in Bio-Europe Spring 2026, held in Lisbon, Portugal, from March 23rd to 25th, 2026, to conduct strategic
More news about: ImmunoForge Co., Ltd.
Mar 12, 2026, 04:25 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
RARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Mar 12, 2026, 04:21 ET Des chefs-d'œuvre d'artisanat, de gastronomie et de culture : la «JAPAN SUI COLLECTION à Paris » captive 200 leaders européens au Royal Monceau
pionnières - comme l'application d'une laque traditionnelle sur du cuir véritable, un concept entièrement nouveau pour le marché européen - combinée à la rare opportunité d'entendre l'artiste lui-même partager les « histoires inédites » et la passion qui se cachent derrière ses créations, a eu un impact profond
More news about: Cabinet Office, Government of Japan
Mar 12, 2026, 04:18 ET Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE
RARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of RARE during the class period listed are encouraged
More news about: DJS Law Group LLP
Mar 11, 2026, 20:01 ET The Urology Foundation launches bold #NameIt campaign tapping into surprising creativity of British men's anatomy nicknames - from Big Ben to Long Dong Silver
humour-led creative to overcome embarrassment, a key barrier preventing many men from discussing intimate symptoms or seeking help.Penile cancer is rare but rising, with more than 760 men diagnosed in the UK each year. Most cases are seen in men aged over 50 but an increasing number of younger people
More news about: The Urology Foundation